Prognostic significance of receptor for hyaluronan acid-mediated motility (CD168) in acute pediatric leukemias - assessment of clinical outcome, post induction, end of treatment and minimal residual disease

about

Prognostic significance of receptor for hyaluronan acid-mediated motility (CD168) in acute pediatric leukemias - assessment of clinical outcome, post induction, end of treatment and minimal residual disease

Item

http://www.wikidata.org/entity/Q58124882

description

wetenschappelijk artikel

@nl

name

Prognostic significance of rec ...... t and minimal residual disease

@en

Prognostic significance of rec ...... t and minimal residual disease

@nl

type

Item

label

Prognostic significance of rec ...... t and minimal residual disease

@en

Prognostic significance of rec ...... t and minimal residual disease

@nl

prefLabel

Prognostic significance of rec ...... t and minimal residual disease

@en

Prognostic significance of rec ...... t and minimal residual disease

@nl

P1476

Prognostic significance of rec ...... t and minimal residual disease

@en

P2093

Chinnathambi Narayanan Sai Shalini

http://www.w3.org/2001/XMLSchema#string

Febe Renjitha Suman

http://www.w3.org/2001/XMLSchema#string

Jerusha Samuela Jacob

http://www.w3.org/2001/XMLSchema#string

Julius Xavier Scott

http://www.w3.org/2001/XMLSchema#string

Magadha Sneha Latha

http://www.w3.org/2001/XMLSchema#string

Rithika Rajendran

http://www.w3.org/2001/XMLSchema#string

P2860

The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells

Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells

Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity

Overexpression of the receptor for hyaluronan-mediated motility (RHAMM) characterizes the malignant clone in multiple myeloma: identification of three distinct RHAMM variants

Potential role for hyaluronan and the hyaluronan receptor RHAMM in mobilization and trafficking of hematopoietic progenitor cells

Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia

Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia

Putting tumours in context

Multidrug resistance in cancer: role of ATP-dependent transporters

Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells

P304

310-316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.HTCT.2018.01.008

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P698

30370408

http://www.w3.org/2001/XMLSchema#string

P932

6200675

http://www.w3.org/2001/XMLSchema#string